These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...
Bayer will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the ...
Registered Dietitian and Nutritionist Kelly Bristow from Bayer shares five simple tips to help families start the year strong ...
Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...
On the occasion of the 43rd J.P. Morgan Healthcare Conference in San Francisco, Bayer AG announces further progress in its pharmaceutical growth strategy with multiple regulatory filing submissions ...
Female entrepreneurs in the fields of health and food security have the chance to receive significant support through the ...
Bayer AG plans to push pause on some of its pharmaceutical dealmaking, focusing instead on reducing the high debt load the ...